This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (145)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal

A Population-Based Cohort Study

John A. Heit, MD; David N. Mohr, MD; Marc D. Silverstein, MD; Tanya M. Petterson, MS; W. Michael O'Fallon, PhD; L. Joseph Melton III, MD

Arch Intern Med. 2000;160:761-768.

Background  The appropriate duration of oral anticoagulation after a first episode of venous thromboembolism (VTE) is uncertain and depends upon VTE recurrence rates.

Objective  To estimate VTE recurrence rates and determine predictors of recurrence.

Methods  Patients in Olmsted County, Minnesota, with a first lifetime deep vein thrombosis or pulmonary embolism diagnosed during the 25-year period from 1966 through 1990 (N = 1719) were followed forward in time through their complete medical records in the community for first VTE recurrence.

Results  Four hundred four patients developed recurrent VTE during 10 198 person-years of follow-up. The overall (probable/definite) cumulative percentages of VTE recurrence at 7, 30, and 180 days and 1 and 10 years were 1.6% (0.2%), 5.2% (1.4%), 10.1% (4.1%), 12.9% (5.6%), and 30.4% (17.6%), respectively. The risk of recurrence was greatest in the first 6 to 12 months after the initial event but never fell to zero. Independent predictors of first overall VTE recurrence included increasing age and body mass index, neurologic disease with paresis, malignant neoplasm, and neurosurgery during the period from 1966 through 1980. Independent predictors of first probable/definite recurrence included diagnostic certainty of the incident event and neurologic disease in patients with hospital-acquired VTE. Recurrence risk was increased by malignant neoplasm but varied with concomitant chemotherapy, patient age and sex, and study year.

Conclusions  Venous thromboembolism recurs frequently, especially within the first 6 to 12 months, and continues to recur for at least 10 years after the initial VTE. Patients with VTE with neurologic disease and paresis or with malignant neoplasm are at increased risk for recurrence, while VTE patients with transient or reversible risk factors are at less risk.

From the Division of Cardiovascular Diseases and the Section of Hematology Research (Dr Heit) and the Division of Area General Internal Medicine (Drs Mohr and Silverstein), Department of Internal Medicine, and the Sections of Clinical Epidemiology (Drs Silverstein and Melton) and Biostatistics (Ms Petterson and Dr O'Fallon), Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, Minn. Dr Silverstein is now with the Center for Health Care Research, Medical University of South Carolina, Charleston.

RELATED ARTICLES

Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Case-Control Study
John A. Heit, Marc D. Silverstein, David N. Mohr, Tanya M. Petterson, W. Michael O'Fallon, and L. Joseph Melton III
Arch Intern Med. 2000;160(6):809-815.
ABSTRACT | FULL TEXT  

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2000;160(6):873-874.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
Rodger et al.
CMAJ 2008;179:417-426.
ABSTRACT | FULL TEXT  

Venous thromboembolism in women
Rathbun
Vasc Med 2008;13:255-266.
ABSTRACT  

Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study
Siragusa et al.
Blood 2008;112:511-515.
ABSTRACT | FULL TEXT  

Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Kearon et al.
Chest 2008;133:454S-545S.
ABSTRACT | FULL TEXT  

Review of the Relationship Between Venous Thromboembolism, Malignancy and Its Treatment
Brown and Herrington
Journal of Pharmacy Practice 2008;21:126-137.
ABSTRACT  

Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous Thromboembolism: Findings From the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry
Laporte et al.
Circulation 2008;117:1711-1716.
ABSTRACT | FULL TEXT  

Current Treatment of Acute Lower Extremity Deep Venous Thrombosis
Janjigian and Muhs
INT J LOW EXTREM WOUNDS 2008;7:15-20.
ABSTRACT  

The Epidemiology of Venous Thromboembolism in the Community
Heit
Arterioscler. Thromb. Vasc. Bio. 2008;28:370-372.
FULL TEXT  

CDC Division of Blood Disorders: Public Health Research Activities in Venous Thromboembolism
Beckman et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:394-395.
FULL TEXT  

Patient Outcomes After Deep Vein Thrombosis and Pulmonary Embolism: The Worcester Venous Thromboembolism Study
Spencer et al.
Arch Intern Med 2008;168:425-430.
ABSTRACT | FULL TEXT  

The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: Strategies for Improving VTE Prophylaxis in Hospitalized Cancer Patients
Khorana
The Oncologist 2007;12:1361-1370.
ABSTRACT | FULL TEXT  

Venous thrombosis in the elderly: more questions than answers
Silverstein et al.
Blood 2007;110:3097-3101.
FULL TEXT  

Risk of recurrence after a first venous thromboembolic event in young women
Laczkovics et al.
haematol 2007;92:1201-1207.
ABSTRACT | FULL TEXT  

Management of Venous Thromboembolism: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians
Snow et al.
ANN INTERN MED 2007;146:204-210.
ABSTRACT | FULL TEXT  

Management of Venous Thromboembolism: A Systematic Review for a Practice Guideline
Segal et al.
ANN INTERN MED 2007;146:211-222.
ABSTRACT | FULL TEXT  

The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
Prandoni et al.
haematol 2007;92:199-205.
ABSTRACT | FULL TEXT  

Management of Venous Thromboembolism: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians
Snow et al.
Ann Fam Med 2007;5:74-80.
ABSTRACT | FULL TEXT  

A Prospective Long-term Study of 220 Patients With a Retrievable Vena Cava Filter for Secondary Prevention of Venous Thromboembolism
Mismetti et al.
Chest 2007;131:223-229.
ABSTRACT | FULL TEXT  

Thrombophilia: Common Questions on Laboratory Assessment and Management
Heit
ASH Education Book 2007;2007:127-135.
ABSTRACT | FULL TEXT  

D-Dimer Testing to Determine the Duration of Anticoagulation Therapy
Palareti et al.
NEJM 2006;355:1780-1789.
ABSTRACT | FULL TEXT  

Homozygosity in the Single Nucleotide Polymorphism Ser128Arg in the E-Selectin Gene Associated With Recurrent Venous Thromboembolism.
Jilma et al.
Arch Intern Med 2006;166:1655-1659.
ABSTRACT | FULL TEXT  

Pulmonary Embolism After Major Abdominal Surgery in Gynecologic Oncology.
Martino et al.
Obstet Gynecol 2006;107:666-671.
ABSTRACT | FULL TEXT  

How I treat venous thromboembolism in patients with cancer
Prandoni
Blood 2005;106:4027-4033.
ABSTRACT | FULL TEXT  

Oral Direct Thrombin Inhibitor Ximelagatran Compared with Warfarin for the Prevention of Venous Thromboembolism After Total Knee Arthroplasty
Colwell et al.
JBJS 2005;87:2169-2177.
ABSTRACT | FULL TEXT  

Recurrence Rate After a First Venous Thrombosis in Patients With Familial Thrombophilia
Vossen et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:1992-1997.
ABSTRACT | FULL TEXT  

Eight-Year Follow-Up of Patients With Permanent Vena Cava Filters in the Prevention of Pulmonary Embolism: The PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) Randomized Study
The PREPIC Study Group
Circulation 2005;112:416-422.
ABSTRACT | FULL TEXT  

Bed Rest or Ambulation in the Initial Treatment of Patients With Acute Deep Vein Thrombosis or Pulmonary Embolism: Findings From the RIETE Registry
Trujillo-Santos et al.
Chest 2005;127:1631-1636.
ABSTRACT | FULL TEXT  

Inherited Risk Factors for Venous Thrombosis
Cushman
ASH Education Book 2005;2005:452-457.
ABSTRACT | FULL TEXT  

Prevention of Recurrent Idiopathic Venous Thromboembolism
Goldhaber
Circulation 2004;110:IV-20-IV-24.
ABSTRACT | FULL TEXT  

Long-Term Management of Patients After Venous Thromboembolism
Kearon
Circulation 2004;110:I-10-I-18.
ABSTRACT | FULL TEXT  

Outcomes and Cost of Deep Venous Thrombosis Among Patients With Cancer
Elting et al.
Arch Intern Med 2004;164:1653-1661.
ABSTRACT | FULL TEXT  

Deep Venous Thrombosis
Lopez et al.
ASH Education Book 2004;2004:439-456.
ABSTRACT | FULL TEXT  

The Potential Role of Direct Thrombin Inhibitors in the Prevention and Treatment of Venous Thromboembolism
Heit
Chest 2003;124:40S-48S.
ABSTRACT | FULL TEXT  

The Epidemiology of Venous Thromboembolism
White
Circulation 2003;107:I-4-8.
ABSTRACT | FULL TEXT  

Natural History of Venous Thromboembolism
Kearon
Circulation 2003;107:I-22-30.
ABSTRACT | FULL TEXT  

British Thoracic Society guidelines for the management of suspected acute pulmonary embolism
Thorax 2003;58:470-483.
FULL TEXT  

Thrombotic Disorders: Diagnosis and Treatment
Schafer et al.
ASH Education Book 2003;2003:520-539.
ABSTRACT | FULL TEXT  

Female Hormones and Thrombosis
Rosendaal et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:201-210.
ABSTRACT | FULL TEXT  

Predictors of Recurrent Venous Thromboembolism
JWatch General 2000;2000:2-2.
FULL TEXT